During the past decade, Austin Regional Clinic, P.A. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Regional Clinic, P.A." #1 sponsor was "R-Pharm International, LLC" with 3 trials, followed by "Biogen" with 1 trials sponsored, "EMD Serono" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Regional Clinic, P.A." #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Austin Regional Clinic, P.A." are "Rheumatoid Arthritis" (4 trials), "Systemic Lupus Erythematosus" (2 trials), "Active Cutaneous Lupus Erythematosus" (1 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Austin Regional Clinic, P.A." in a lesser frequency.

Most popular intervention types in "Austin Regional Clinic, P.A." are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials), "Adalimumab 40mg q2w" (1 trials) and "Atacicept 150 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Regional Clinic, P.A." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Austin Regional Clinic, P.A.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Austin Regional Clinic, P.A., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Regional Clinic, P.A., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".